Author: DELFI Diagnostics

Posted Date:

May 28, 2026

DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States

DELFI Diagnostics

May 28, 2026
DELFI Diagnostics to Present First Clinical Utility Data for Blood-Based Lung Cancer Screening at ATS 2026 International Conference

DELFI Diagnostics

May 21, 2026
DELFI Diagnostics Appoints Charles Newton to Board of Directors

DELFI Diagnostics

April 27, 2026
DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting

DELFI Diagnostics

April 6, 2026